Abstract
Teicoplanin is a glycopeptide antibiotic (GPAs)used to treat infections by Gram-positive bacterial pathogens. GPAs are natural products and due to their complex structure we rely on bacterial fermentation for their production. Consequently, we need to understand GPA biosynthesis to develop new compounds for clinical use. Herein, we structurally characterise an amino acid selection domain integral to the synthesis of the GPA, explore the evolution of these domains to reveal how ancestral forms of these proteins evolved to accept new amino acid building blocks, and learn how to modify these domains by understanding natural evolution in biosynthesis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.